These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27308542)

  • 1. Dormancy programs as emerging antimetastasis therapeutic alternatives.
    Sosa MS
    Mol Cell Oncol; 2016 Jan; 3(1):e1029062. PubMed ID: 27308542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes.
    Sosa MS; Parikh F; Maia AG; Estrada Y; Bosch A; Bragado P; Ekpin E; George A; Zheng Y; Lam HM; Morrissey C; Chung CY; Farias EF; Bernstein E; Aguirre-Ghiso JA
    Nat Commun; 2015 Jan; 6():6170. PubMed ID: 25636082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
    Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
    BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
    Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
    J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic and Pluripotency Aspects of Disseminated Cancer Cells During Minimal Residual Disease.
    Carlini MJ; Shrivastava N; Sosa MS
    Adv Exp Med Biol; 2018; 1100():1-18. PubMed ID: 30411257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.
    Bleau AM; Agliano A; Larzabal L; de Aberasturi AL; Calvo A
    Histol Histopathol; 2014 Dec; 29(12):1499-510. PubMed ID: 24887025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.
    Muzes G; Sipos F
    Anticancer Agents Med Chem; 2017; 17(4):472-482. PubMed ID: 27592547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of a 26-year-old woman with West syndrome and an nuclear receptor subfamily 2 group F member 1 gene (NR2F1) mutation.
    Hino-Fukuyo N; Kikuchi A; Yokoyama H; Iinuma K; Hirose M; Haginoya K; Niihori T; Nakayama K; Aoki Y; Kure S
    Seizure; 2017 Aug; 50():144-146. PubMed ID: 28654857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
    Allgayer H; Aguirre-Ghiso JA
    APMIS; 2008; 116(7-8):602-14. PubMed ID: 18834405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ATP7A to increase the sensitivity of neuroblastoma cells to retinoid therapy.
    Cheung BB; Marshall GM
    Curr Cancer Drug Targets; 2011 Sep; 11(7):826-36. PubMed ID: 21762080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress.
    Dai Y; Wang L; Tang J; Cao P; Luo Z; Sun J; Kiflu A; Sai B; Zhang M; Wang F; Li G; Xiang J
    Oncotarget; 2016 May; 7(18):25478-92. PubMed ID: 27009858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids in cancer chemoprevention.
    Okuno M; Kojima S; Matsushima-Nishiwaki R; Tsurumi H; Muto Y; Friedman SL; Moriwaki H
    Curr Cancer Drug Targets; 2004 May; 4(3):285-98. PubMed ID: 15134535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR2F1 mediated down-regulation of osteoblast differentiation was rescued by bone morphogenetic protein-2 (BMP-2) in human MSC.
    Manikandan M; Abuelreich S; Elsafadi M; Alsalman H; Almalak H; Siyal A; Hashmi JA; Aldahmash A; Kassem M; Alfayez M; Mahmood A
    Differentiation; 2018; 104():36-41. PubMed ID: 30445268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle arrest in plants: what distinguishes quiescence, dormancy and differentiated G1?
    Velappan Y; Signorelli S; Considine MJ
    Ann Bot; 2017 Oct; 120(4):495-509. PubMed ID: 28981580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retinoid signalling pathways].
    Fukasawa H; Shudo K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Author Correction: Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63.
    Liu Y; Zhang P; Wu Q; Fang H; Wang Y; Xiao Y; Cong M; Wang T; He Y; Ma C; Tian P; Liang Y; Qin LX; Yang Q; Yang Q; Liao L; Hu G
    Nat Commun; 2021 Oct; 12(1):5973. PubMed ID: 34620868
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular mechanisms underlying tumor dormancy.
    Almog N
    Cancer Lett; 2010 Aug; 294(2):139-46. PubMed ID: 20363069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms and implications of cancer cell dormancy in head and neck carcinoma].
    Xiaolei G; Xinhua L; Yaling T
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Feb; 36(1):92-98. PubMed ID: 29595004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases.
    Drescher F; Juárez P; Arellano DL; Serafín-Higuera N; Olvera-Rodriguez F; Jiménez S; Licea-Navarro AF; Fournier PG
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.